Immune Checkpoint Inhibitor Therapy Associated Hypophysitis

Ipilimumab is a monoclonal antibody directed against CTLA4 T-lymphocyte antigen used as cancer therapy. Immune-related adverse events are common side effects and may include hypophysitis-related hypopituitarism. The clinical features of six patients with ipilimumab-induced hypophysitis (IH) are desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahzari, Moeber, Liu, Dora, Arnaout, Amel, Lochnan, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376202/
https://www.ncbi.nlm.nih.gov/pubmed/25861234
http://dx.doi.org/10.4137/CMED.S22469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376202/
https://www.ncbi.nlm.nih.gov/pubmed/25861234
http://dx.doi.org/10.4137/CMED.S22469

Ejemplares similares